Center for Scientific Review; Notice of Closed Meetings, 72498-72499 [2023-23235]
Download as PDF
<![CDATA[
72498
Federal Register / Vol. 88, No. 202 / Friday, October 20, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
Center for Scientific Review; Notice of
Closed Meetings
In accordance with title 41 of the U.S.
Code of Federal Regulations, Section
102–3.65(a), notice is hereby given that
the Charter for the National Cancer
Institute Board of Scientific Advisors,
was renewed for an additional two-year
period on October 8, 2023.
It is determined that the National
Cancer Institute Board of Scientific
Advisors, is in the public interest in
connection with the performance of
duties imposed on the National
Institutes of Health by law, and that
these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@mail.nih.gov.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23266 Filed 10–19–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel Member
Conflict: Clinical Care and Health
Interventions, November 20, 2023, 9:00
a.m.–8:00 p.m., National Institutes of
Health, 6701 Rockledge Drive, Bethesda,
MD 20892, which was published in the
Federal Register on September 29, 2023,
88 FR 67329 Doc 2023–21352.
This meeting is being amended to
start on November 15, 2023, from 9:30
a.m.–2:30 p.m. The meeting is closed to
the public.
Dated: October 16, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23233 Filed 10–19–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:20 Oct 19, 2023
Jkt 262001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biological Chemistry and
Macromolecular Biophysics.
Date: November 14, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ian Frederick Thorpe,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 903K,
Bethesda, MD 20892, (301) 480–8662,
ian.thorpe@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Evaluation
of National Cryo-EM Centers.
Date: November 15, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nuria E. Assa-Munt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4164,
MSC 7806, Bethesda, MD 20892, (301) 451–
1323, assamunu@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Musculoskeletal Sciences in
Diagnostics, Devices, and Rehabilitation.
Date: November 16–17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Amber Taylor Collins,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
MD 20892, (301) 827–5245, amber.collins@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
22–034: HEAL Initiative.
Date: November 21, 2023.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne-Sophie Marie Lucie
Wattiez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–4642, annesophie.wattiez@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention and Therapy.
Date: December 5, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockville Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, (301) 443–
1196, laura.asnaghi@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts in Hepatology, Pharmacology and
Toxicology.
Date: December 6, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Frederique Yiannikouris,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3313,
frederique.yiannikouris@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Anti-Infective Therapeutics.
Date: December 6–7, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marcus Ferrone,
PHARMD, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–2371, marcus.ferrone@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\20OCN1.SGM
20OCN1
Federal Register / Vol. 88, No. 202 / Friday, October 20, 2023 / Notices
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23235 Filed 10–19–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ddrumheller on DSK120RN23PROD with NOTICES1
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361 or
email Carlos.Graham@samhsa.hhs.gov.
Project: Assessment of the Communities
Talk To Prevent Alcohol and Other
Drug Misuse (Formerly Communities
Talk To Prevent Underage Drinking—
OMB No. 0930–0288) Revision
The Substance Abuse and Mental
Health Services Administration/Center
for Substance Abuse Prevention
(SAMHSA/CSAP) is requesting a
revision from the Office of Management
and Budget (OMB) for the information
collection regarding the Assessment of
the Communities Talk to Prevent
Alcohol and Other Drug Misuse
initiative, which is implemented by the
Substance Use Disorder Prevention
Engagement Initiatives (SUDPEI) within
CSAP. Communities Talk activities are
grassroots activities that raise awareness
of the public health dangers of
substance misuse and engage
communities in evidence-based
prevention, particularly to individuals
aged 12–25 years old. In this survey,
substance use disorder (SUD) questions
refers to any alcohol or drugs used in
the 12 months prior to the survey and
the language ‘‘alcohol and other drug
72499
misuse’’ will be used to ask questions
about SUDs throughout the survey.
Alcohol misuse includes any underage
use of alcohol. Other drug misuse
includes use of marijuana, cocaine
(including crack), heroin, hallucinogens,
inhalants, methamphetamine, and any
use of prescription stimulants,
tranquilizers or sedatives (e.g.,
benzodiazepines), and pain relievers.1
The data collection was most recently
reinstated under OMB No. 0930–0288,
Assessment of the Town Hall Meetings
on Underage Drinking Prevention,
which expires on May 31, 2025.
Changes
Under the most recent approval, the
Organizer Survey consisted of 14 items.
Under this amendment, the Organizer
Survey includes 12 items about
Communities Talk activities and how
communities might be carrying out
evidence-based strategies to prevent
alcohol and other drug misuse. The
following table provides a summary of
the changes that were made to the
instrument.
Current question/item
Changes made
Burden statement .....................................................................................
Updated with language provided by SAMHSA to include ‘‘alcohol and
other drug misuse’’ verbiage: ‘This information is being collected to
assist the Substance Abuse and Mental Health Services Administration (SAMHSA) for the purpose of program monitoring of the Communities Talk to Prevent Alcohol and Other Drug Misuse initiative.
This voluntary information collected will be used at an aggregate
level to assess the Communities Talk stipend recipients’ experiences
with the events and alcohol and other drug misuse prevention activities deployed by their organizations or institutions. Under the Privacy
Act of 1974, any personally identifying information obtained will be
kept private to the extent of the law. An agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid Office of Management
and Budget (OMB) control number. The OMB control number for this
project is 0930–0288. Public reporting burden for this collection of information is estimated to average 15 minutes per encounter, including the time for reviewing instructions, searching existing data
sources, gathering and maintaining the data needed, and completing
and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to
SAMHSA Reports Clearance Officer, 5600 Fishers Ln, Room 15
E57B, Rockville, MD 20857.’
1 Substance Abuse and Mental Health Services
Administration. (2022). Highlights for the 2021
VerDate Sep<11>2014
18:20 Oct 19, 2023
Jkt 262001
National Survey on Drug Use and Health. https://
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
www.samhsa.gov/data/sites/default/files/2022-12/
2021NSDUHFFRHighlights092722.pdf.
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 88, Number 202 (Friday, October 20, 2023)]
[Notices]
[Pages 72498-72499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23235]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Biological Chemistry and Macromolecular
Biophysics.
Date: November 14, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ian Frederick Thorpe, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 903K, Bethesda, MD 20892, (301)
480-8662, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Evaluation of National Cryo-EM Centers.
Date: November 15, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nuria E. Assa-Munt, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD
20892, (301) 451-1323, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Musculoskeletal Sciences in Diagnostics,
Devices, and Rehabilitation.
Date: November 16-17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Amber Taylor Collins, Ph.D., Scientific Review
Officer, The Center for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-5245,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-22-034: HEAL Initiative.
Date: November 21, 2023.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne-Sophie Marie Lucie Wattiez, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,
(301) 594-4642, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Prevention and Therapy.
Date: December 5, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockville Drive, Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
1196, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts in Hepatology, Pharmacology and Toxicology.
Date: December 6, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Frederique Yiannikouris, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3313,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Anti-Infective Therapeutics.
Date: December 6-7, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marcus Ferrone, PHARMD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-2371,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 72499]]
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-23235 Filed 10-19-23; 8:45 am]
BILLING CODE 4140-01-P
